Clonazepam in facial neuralgia and cluster headache. Clinical and electrophysiological study.
Clonazepam seems to be an effective drug in idiopathic trigeminal neuralgia. Electrophysiological investigations support the idea that this neuralgia is due to a loss of central inhibition. During the first 1-2 weeks of treatment marked drowsiness is observed in the majority of cases. In one case, presence of a synergism between Clonazepam and L-dopa+ inhibitor was also observed.
D000328:Adult; D000368:Aged; D001570:Benzodiazepinones / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D002998:Clonazepam / Q000627:therapeutic use*; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014277:Trigeminal Neuralgia / Q000188:drug therapy*; D014653:Vascular Headaches / Q000188:drug therapy*
D001570:Benzodiazepinones; D002998:Clonazepam